{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:02:13Z","timestamp":1789516933803,"version":"build-2803163510"},"reference-count":130,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["SWU2509744"],"award-info":[{"award-number":["SWU2509744"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003803","name":"University of Hong Kong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32250610208"],"award-info":[{"award-number":["32250610208"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32500964"],"award-info":[{"award-number":["32500964"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271583"],"award-info":[{"award-number":["82271583"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["23243971"],"award-info":[{"award-number":["23243971"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.molmed.2025.10.001","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T16:14:04Z","timestamp":1760804044000},"page":"429-445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Renin\u2013angiotensin system: a novel target for brain health"],"prefix":"10.1016","volume":"32","author":[{"given":"Ting","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2025.10.001_bb0005","doi-asserted-by":"crossref","first-page":"62","DOI":"10.6002\/ect.IAHNCongress.15","article-title":"Robert Tigerstedt and the discovery of renin","volume":"21","author":"Ostrowski","year":"2023","journal-title":"Exp. Clin. Transplant."},{"key":"10.1016\/j.molmed.2025.10.001_bb0010","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.3390\/ijms25074035","article-title":"Renin-angiotensin-aldosterone system: from history to practice of a secular topic","volume":"25","author":"Ksiazek","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2025.10.001_bb0015","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1161\/ATVBAHA.118.311282","article-title":"Renin-angiotensin system and cardiovascular functions","volume":"38","author":"Wu","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413320","article-title":"Angiotensin-(1-7) and central control of cardiometabolic outcomes: implications for obesity hypertension","volume":"25","author":"Vernail","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2025.10.001_bb0025","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3390\/ijms19030876","article-title":"Within the brain: the renin angiotensin system","volume":"19","author":"Jackson","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2025.10.001_bb0030","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1161\/HYPERTENSIONAHA.123.21367","article-title":"Kidney renin-angiotensin system: lost in a RAS cascade","volume":"81","author":"Crowley","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.molmed.2025.10.001_bb0035","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1038\/s41380-023-02001-6","article-title":"Angiotensin blockade enhances motivational reward learning via enhancing striatal prediction error signaling and frontostriatal communication","volume":"28","author":"Xu","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.molmed.2025.10.001_bb0040","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1523\/JNEUROSCI.1114-22.2022","article-title":"The angiotensin antagonist Losartan modulates social reward motivation and punishment sensitivity via modulating midbrain-striato-frontal circuits","volume":"43","author":"Zhou","year":"2023","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2025.10.001_bb0045","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.biopsych.2019.04.010","article-title":"The effects of the angiotensin II receptor antagonist losartan on appetitive versus aversive learning: a randomized controlled trial","volume":"86","author":"Pulcu","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2025.10.001_bb0050","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.biopsych.2024.01.020","article-title":"Reduction of aversive learning rates in Pavlovian conditioning by angiotensin II antagonist losartan: a randomized controlled trial","volume":"96","author":"Zika","year":"2024","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2025.10.001_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2025.116458","article-title":"Angiotensin receptor blockade modulates resting state functional connectivity in the memory network rather than fear network\u2013implications for posttraumatic stress disorder","author":"Shkreli","year":"2025","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.molmed.2025.10.001_bb0060","article-title":"The central renin\u2013angiotensin system: a genetic pathway, functional decoding, and selective target engagement characterization in humans","volume":"121","author":"Xu","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2025.10.001_bb0065","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41398-019-0374-0","article-title":"Estradiol modulation of the renin\u2013angiotensin system and the regulation of fear extinction","volume":"9","author":"Parrish","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.molmed.2025.10.001_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-017-0916-3","article-title":"The renin\u2013angiotensin system: a possible new target for depression","volume":"15","author":"Vian","year":"2017","journal-title":"BMC Med."},{"key":"10.1016\/j.molmed.2025.10.001_bb0075","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jad.2019.08.075","article-title":"Distinct effects of antihypertensives on depression in the real-world setting: a retrospective cohort study","volume":"259","author":"Cao","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.molmed.2025.10.001_bb0080","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/0004867417721654","article-title":"Blockade of the angiotensin system improves mental health domain of quality of life: a meta-analysis of randomized clinical trials","volume":"52","author":"Brownstein","year":"2018","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.molmed.2025.10.001_bb0085","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3390\/pharmaceutics15092290","article-title":"Therapeutic implications of renin\u2013angiotensin system modulators in Alzheimer\u2019s dementia","volume":"15","author":"Ababei","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.molmed.2025.10.001_bb0090","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s11357-020-00231-y","article-title":"Brain angiotensin II and angiotensin IV receptors as potential Alzheimer\u2019s disease therapeutic targets","volume":"42","author":"Royea","year":"2020","journal-title":"Geroscience"},{"key":"10.1016\/j.molmed.2025.10.001_bb0095","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s12916-024-03704-5","article-title":"Use of renin-angiotensin system blockers and posttraumatic stress disorder risk in the UK Biobank: a retrospective cohort study","volume":"22","author":"Kang","year":"2024","journal-title":"BMC Med."},{"key":"10.1016\/j.molmed.2025.10.001_bb0100","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.biopsych.2021.02.140","article-title":"Renin-angiotensin system blockade is associated with decreased likelihood of PTSD","volume":"89","author":"Seligowski","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2025.10.001_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2025.1565270","article-title":"Angiotensin-(1-7) protective effects in neurocognitive disorders: molecular mechanisms to therapeutic implications","volume":"16","author":"Lucas","year":"2025","journal-title":"Front. Physiol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0110","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1007\/s00429-016-1357-z","article-title":"Expression of angiotensinogen and receptors for angiotensin and prorenin in the rat and monkey striatal neurons and glial cells","volume":"222","author":"Garrido-Gil","year":"2017","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.molmed.2025.10.001_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252312644","article-title":"Potentiation of NMDA receptors by AT1 angiotensin receptor activation in Layer V pyramidal neurons of the rat prefrontal cortex","volume":"25","author":"Hanuska","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2025.10.001_bb0120","doi-asserted-by":"crossref","first-page":"H461","DOI":"10.1152\/ajpheart.00582.2019","article-title":"Differential expression of angiotensin II type 1 receptor subtypes within the cerebral microvasculature","volume":"318","author":"Yamasaki","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109460","article-title":"Central amygdala angiotensin type 1 receptor (Agtr1) expressing neurons contribute to fear extinction","volume":"229","author":"Yu","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.molmed.2025.10.001_bb0130","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s13311-018-0646-z","article-title":"Angiotensin type 1 receptor antagonists protect against alpha-synuclein-induced neuroinflammation and dopaminergic neuron death","volume":"15","author":"Rodriguez-Perez","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.molmed.2025.10.001_bb0135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12012-022-09730-0","article-title":"AT1 receptors: their actions from hypertension to cognitive impairment","volume":"22","author":"Wu","year":"2022","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0140","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00109-016-1406-3","article-title":"Angiotensin AT2-receptor stimulation improves survival and neurological outcome after experimental stroke in mice","volume":"94","author":"Schwengel","year":"2016","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.molmed.2025.10.001_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104644","article-title":"Memory and cerebrovascular deficits recovered following angiotensin IV intervention in a mouse model of Alzheimer's disease","volume":"134","author":"Royea","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.molmed.2025.10.001_bb0150","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1523\/JNEUROSCI.0329-17.2017","article-title":"Angiotensin IV receptors mediate the cognitive and cerebrovascular benefits of losartan in a mouse model of Alzheimer's disease","volume":"37","author":"Royea","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molmed.2025.10.001_bb0155","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1007\/s12640-021-00403-4","article-title":"The protective effects of AT2R agonist, CGP42112A, against angiotensin II-induced oxidative stress and inflammatory response in astrocytes: role of AT2R\/PP2A\/NF\u03baB\/ROS signaling","volume":"39","author":"Bhat","year":"2021","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.molmed.2025.10.001_bb0160","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1007\/s12035-017-0805-y","article-title":"Paracrine and intracrine angiotensin 1-7\/Mas receptor axis in the substantia nigra of rodents, monkeys, and humans","volume":"55","author":"Costa-Besada","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0165","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/angiotensin-(1-7)\/MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.molmed.2025.10.001_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11906-023-01266-0","article-title":"Angiotensin receptor blockers and cognition: a scoping review","volume":"26","author":"Zhou","year":"2024","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.molmed.2025.10.001_bb0175","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1007\/s12035-020-01964-9","article-title":"The brain AT2R-a potential target for therapy in Alzheimer's disease and vascular cognitive impairment: a comprehensive review of clinical and experimental therapeutics","volume":"57","author":"Ahmed","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0180","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1152\/physiolgenomics.00029.2016","article-title":"Angiotensin type 1a receptors in the paraventricular nucleus of the hypothalamus control cardiovascular reactivity and anxiety-like behavior in male mice","volume":"48","author":"Wang","year":"2016","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.molmed.2025.10.001_bb0185","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/sctm.16-0382","article-title":"Angiotensin II causes apoptosis of adult hippocampal neural stem cells and memory impairment through the action on AMPK-PGC1\u03b1 signaling in heart failure","volume":"6","author":"Kim","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.molmed.2025.10.001_bb0190","doi-asserted-by":"crossref","first-page":"7949","DOI":"10.1111\/jcmm.15427","article-title":"Losartan attenuates neuroinflammation and neuropathic pain in paclitaxel-induced peripheral neuropathy","volume":"24","author":"Kalynovska","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.molmed.2025.10.001_bb0195","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.freeradbiomed.2024.12.004","article-title":"Spinal AT1R contributes to neuroinflammation and neuropathic pain via NOX2-dependent redox signaling in microglia","volume":"227","author":"Zhang","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.molmed.2025.10.001_bb0200","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s12035-017-0450-5","article-title":"Angiotensin II receptor blockers attenuate lipopolysaccharide-induced memory impairment by modulation of NF-\u03baB-mediated BDNF\/CREB expression and apoptosis in spontaneously hypertensive rats","volume":"55","author":"Goel","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0205","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac270","article-title":"Safety and biomarker effects of candesartan in non-hypertensive adults with prodromal Alzheimer\u2019s disease","volume":"4","author":"Hajjar","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.molmed.2025.10.001_bb0210","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.biopsych.2021.05.012","article-title":"Randomized, placebo-controlled trial of the angiotensin receptor antagonist losartan for posttraumatic stress disorder","volume":"90","author":"Stein","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2025.10.001_bb0215","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.12252","article-title":"Effects of candesartan vs lisinopril on neurocognitive function in older adults with executive mild cognitive impairment: a randomized clinical trial","volume":"3","author":"Hajjar","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.molmed.2025.10.001_bb0220","article-title":"Acute Angiotensin II receptor blockade facilitates parahippocampal processing during memory encoding in high-trait-anxious individuals","volume":"4","author":"Shkreli","year":"2024","journal-title":"Biol. Psychiatry Glob. Open Sci."},{"key":"10.1016\/j.molmed.2025.10.001_bb0225","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3233\/JAD-200118","article-title":"Angiotensin II blood levels are associated with smaller hippocampal and cortical volumes in cognitively normal older adults","volume":"75","author":"Yasar","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.molmed.2025.10.001_bb0230","first-page":"970","article-title":"Angiotensin antagonist inhibits preferential negative memory encoding via decreasing hippocampus activation and its coupling with the amygdala","volume":"7","author":"Xu","year":"2022","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.molmed.2025.10.001_bb0235","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.biopsych.2019.07.007","article-title":"Human extinction learning is accelerated by an angiotensin antagonist via ventromedial prefrontal cortex and its connections with basolateral amygdala","volume":"86","author":"Zhou","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2025.10.001_bb0240","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.biopsych.2019.09.026","article-title":"Angiotensin II signaling and fear extinction: translational evidence and novel receptor targets","volume":"86","author":"Stout","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2025.10.001_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154860","article-title":"Losartan modulates brain inflammation and improves mood disorders and memory impairment induced by innate immune activation: The role of PPAR-\u03b3 activation","volume":"125","author":"Salmani","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.molmed.2025.10.001_bb0250","article-title":"Renin-angiotensin system: the underlying mechanisms and promising therapeutical target for depression and anxiety","volume":"13","author":"Gong","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0255","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s13311-018-0613-8","article-title":"Brain renin\u2013angiotensin system blockade attenuates methamphetamine-induced hyperlocomotion and neurotoxicity","volume":"15","author":"Jiang","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.molmed.2025.10.001_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2021.638519","article-title":"The renin\u2013angiotensin system modulates dopaminergic neurotransmission: a new player on the scene","volume":"13","author":"Kobiec","year":"2021","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.molmed.2025.10.001_bb0265","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jocn.2016.02.036","article-title":"The association of renin-angiotensin system blockade use with the risks of cognitive impairment of aging and Alzheimer\u2019s disease: a meta-analysis","volume":"33","author":"Zhuang","year":"2016","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.molmed.2025.10.001_bb0270","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jamda.2020.12.019","article-title":"Antihypertensive medication classes and the risk of dementia: a systematic review and network meta-analysis","volume":"22","author":"den Brok","year":"2021","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.molmed.2025.10.001_bb0275","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1474-4422(19)30393-X","article-title":"Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies","volume":"19","author":"Ding","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0280","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1212\/WNL.0000000000008732","article-title":"Investigation of antihypertensive class, dementia, and cognitive decline: a meta-analysis","volume":"94","author":"Peters","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.molmed.2025.10.001_bb0285","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/jnnp-2019-321913","article-title":"Evidence-based prevention of Alzheimer\u2019s disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials","volume":"91","author":"Yu","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.molmed.2025.10.001_bb0290","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S1474-4422(21)00263-5","article-title":"Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"20","author":"Kehoe","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0295","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/HYPERTENSIONAHA.121.17049","article-title":"Blood-brain barrier crossing renin-angiotensin drugs and cognition in the elderly: a meta-analysis","volume":"78","author":"Ho","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.molmed.2025.10.001_bb0300","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3233\/JAD-161198","article-title":"Rationale and design of the mechanistic potential of antihypertensives in preclinical Alzheimer\u2019s (HEART) trial","volume":"61","author":"Wharton","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.molmed.2025.10.001_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2023.114639","article-title":"Sex-dependent effects of angiotensin II type 1 receptor blocker on molecular and behavioral changes induced by single prolonged stress","volume":"454","author":"Ortiz-Nazario","year":"2023","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.molmed.2025.10.001_bb0310","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.biopsych.2021.07.009","article-title":"Failure of losartan in a clinical trial for posttraumatic stress disorder: lack of efficacy or spotlight on the power of placebo?","volume":"90","author":"Torregrossa","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2025.10.001_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-017-0255-9","article-title":"Memory is preserved in older adults taking AT1 receptor blockers","volume":"9","author":"Ho","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.molmed.2025.10.001_bb0320","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.647747","article-title":"Amphetamine induces oxidative stress, glial activation and transient angiogenesis in prefrontal cortex via AT1-R","volume":"12","author":"Basmadjian","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107902","article-title":"Angiotensin II and aldosterone activate retinal microglia","volume":"191","author":"Rana","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.molmed.2025.10.001_bb0330","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fnagi.2017.00129","article-title":"Brain renin-angiotensin system and microglial polarization: implications for aging and neurodegeneration","volume":"9","author":"Labandeira-Garcia","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.molmed.2025.10.001_bb0335","first-page":"13","article-title":"Role of angiotensin II in hepatic inflammation through MAPK pathway: a review","volume":"2","author":"Chowdhury","year":"2016","journal-title":"J. Hepat."},{"key":"10.1016\/j.molmed.2025.10.001_bb0340","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1161\/HYPERTENSIONAHA.123.21070","article-title":"Angiotensin II\u2013mediated neuroinflammation in the hippocampus contributes to neuronal deficits and cognitive impairment in heart failure rats","volume":"80","author":"Althammer","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.molmed.2025.10.001_bb0345","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12035-023-03556-9","article-title":"Higher neuronal facilitation and potentiation with APOE4 suppressed by Angiotensin II","volume":"61","author":"Scheinman","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0350","doi-asserted-by":"crossref","first-page":"R640","DOI":"10.1016\/j.cub.2024.05.008","article-title":"Half a century legacy of long-term potentiation","volume":"34","author":"Caya-Bissonnette","year":"2024","journal-title":"Curr. Biol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0355","first-page":"262","article-title":"Angiotensin II regulates the neural expression of subjective fear in humans: a precision pharmaco-neuroimaging approach","volume":"8","author":"Zhang","year":"2023","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.molmed.2025.10.001_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063488","article-title":"Angiotensin II increased neuronal stem cell proliferation: role of AT2R","volume":"8","author":"Chao","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.molmed.2025.10.001_bb0365","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.bbadis.2016.03.013","article-title":"Angiotensin II type-2 receptor stimulation induces neuronal VEGF synthesis after cerebral ischemia","volume":"1862","author":"Mateos","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2025.10.001_bb0370","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/biomedicines13010071","article-title":"Angiotensin IV receptors in the rat prefrontal cortex: neuronal expression and NMDA inhibition","volume":"13","author":"Papp","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.molmed.2025.10.001_bb0375","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.586314","article-title":"Brain renin-angiotensin system at the intersect of physical and cognitive frailty","volume":"14","author":"Cosarderelioglu","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.molmed.2025.10.001_bb0380","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.3390\/ijms21134572","article-title":"Involvement of ACE2\/Ang-(1-7)\/MAS1 axis in the regulation of ovarian function in mammals","volume":"21","author":"Domi\u0144ska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2025.10.001_bb0385","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejphar.2014.12.007","article-title":"Ang-(1\u20137) exerts protective role in blood\u2013brain barrier damage by the balance of TIMP-1\/MMP-9","volume":"748","author":"Wu","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0390","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/cvr\/cvz332","article-title":"Mas receptor is translocated to the nucleus upon agonist stimulation in brainstem neurons from spontaneously hypertensive rats but not normotensive rats","volume":"116","author":"Cerniello","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.molmed.2025.10.001_bb0395","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.45319","article-title":"Association of antihypertensives that stimulate vs inhibit types 2 and 4 Angiotensin II receptors with cognitive impairment","volume":"5","author":"Marcum","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.molmed.2025.10.001_bb0400","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.49370","article-title":"Association of new use of antihypertensives that stimulate vs inhibit type 2 and 4 Angiotensin II receptors with dementia among medicare beneficiaries","volume":"6","author":"Marcum","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.molmed.2025.10.001_bb0405","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.7150\/ijbs.99617","article-title":"Activation of central Angiotensin-(1-7)\/Mas receptor alleviates synaptic damage in diabetes-associated cognitive impairment via modulating AKT\/FOXO1\/PACAP axis","volume":"21","author":"Tian","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.molmed.2025.10.001_bb0410","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/HYPERTENSIONAHA.120.16667","article-title":"Comparative First-line effectiveness and safety of ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers: a multinational cohort study","volume":"78","author":"Chen","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.molmed.2025.10.001_bb0415","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1007\/s11096-024-01755-5","article-title":"Comparative efficacy and safety of six angiotensin II receptor blockers in hypertensive patients: a network meta-analysis","volume":"46","author":"Zhang","year":"2024","journal-title":"Int. J. Clin. Pharm."},{"key":"10.1016\/j.molmed.2025.10.001_bb0420","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.20680","article-title":"Risk of mild cognitive impairment or probable dementia in new users of Angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors: a secondary analysis of data from the Systolic Blood Pressure Intervention Trial (SPRINT)","volume":"5","author":"Cohen","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.molmed.2025.10.001_bb0425","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.3390\/ijms22179434","article-title":"The antihypertensive drug telmisartan protects oligodendrocytes from cholesterol accumulation and promotes differentiation by a PPAR-\u03b3-mediated mechanism","volume":"22","author":"Bernardo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2025.10.001_bb0430","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/alz.12819","article-title":"Population-based discovery and Mendelian randomization analysis identify telmisartan as a candidate medicine for Alzheimer's disease in African Americans","volume":"19","author":"Zhang","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.molmed.2025.10.001_bb0435","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10571-017-0554-5","article-title":"Roles of peroxisome proliferator-activated receptor gamma on brain and peripheral inflammation","volume":"38","author":"Villapol","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0440","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3390\/brainsci13040615","article-title":"Cognitive processes and resting-state functional neuroimaging findings in high schizotypal individuals and schizotypal personality disorder patients: a systematic review","volume":"13","author":"Zouraraki","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.molmed.2025.10.001_bb0445","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jad.2025.01.119","article-title":"Acute angiotensin receptor blockade and mnemonic discrimination in healthy participants","volume":"375","author":"Prasad","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.molmed.2025.10.001_bb0450","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2201657119","article-title":"Hippocampal ripples signal contextually mediated episodic recall","volume":"119","author":"Sakon","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2025.10.001_bb0455","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1080\/13854046.2023.2184720","article-title":"Subjective memory complaints are associated with decreased cortical thickness in Veterans with histories of mild traumatic brain injury","volume":"37","author":"Ly","year":"2023","journal-title":"Clin. Neuropsychol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0460","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41386-019-0553-y","article-title":"Angiotensin involvement in trauma processing\u2014exploring candidate neurocognitive mechanisms of preventing post-traumatic stress symptoms","volume":"45","author":"Shkreli","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.molmed.2025.10.001_bb0465","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41398-020-01043-6","article-title":"Evaluation of an angiotensin Type 1 receptor blocker on the reconsolidation of fear memory","volume":"10","author":"Swiercz","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.molmed.2025.10.001_bb0470","first-page":"826","article-title":"Angiotensin regulation of amygdala response to threat in high-trait-anxiety individuals","volume":"3","author":"Reinecke","year":"2018","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.molmed.2025.10.001_bb0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11920-019-0987-2","article-title":"A review of the relationship between emotional learning and memory, sleep, and PTSD","volume":"21","author":"Colvonen","year":"2019","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.molmed.2025.10.001_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104553","article-title":"Common and distinct neurofunctional representations of core and social disgust in the brain: coordinate-based and network meta-analyses","volume":"135","author":"Gan","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.molmed.2025.10.001_bb0485","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.biopsych.2019.05.027","article-title":"Angiotensin II type 2 receptor\u2013expressing neurons in the central amygdala influence fear-related behavior","volume":"86","author":"Yu","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2025.10.001_bb0490","doi-asserted-by":"crossref","first-page":"107","DOI":"10.12793\/tcp.2024.32.e10","article-title":"Pharmacokinetics and bioequivalence study of candesartan cilexetil tablet in Chinese volunteers under fasting condition: an open-label, randomized-sequence, 2-period crossover study","volume":"32","author":"Han","year":"2024","journal-title":"Transl. Clin. Pharmacol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0495","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1111\/bcp.15411","article-title":"Angiotensin II receptor blockers (ARBs) and manufacturing contamination: a retrospective National Register Study into suspected associated adverse drug reactions","volume":"88","author":"Salim","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113674","article-title":"Telmisartan ameliorates A\u03b2 oligomer-induced inflammation via PPAR\u03b3\/PTEN pathway in BV2 microglial cells","volume":"171","author":"Wang","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0505","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1042\/CS20240771","article-title":"Candesartan restores blood-brain barrier dysfunction, mitigates aberrant gene expression, and extends lifespan in a knockin mouse model of epileptogenesis","volume":"138","author":"Hammer","year":"2024","journal-title":"Clin. Sci."},{"key":"10.1016\/j.molmed.2025.10.001_bb0510","doi-asserted-by":"crossref","first-page":"10805","DOI":"10.1007\/s12035-024-04237-x","article-title":"Valsartan: an angiotensin receptor blocker modulates BDNF expression and provides neuroprotection against cerebral ischemic reperfusion injury","volume":"61","author":"Ali","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0515","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1007\/s12035-017-0812-z","article-title":"Angiotensin II causes neuronal damage in stretch-injured neurons: protective effects of losartan, an Angiotensin T(1) receptor blocker","volume":"55","author":"Muneer","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0520","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/gerona\/glac101","article-title":"Losartan mitigates oxidative stress in the brains of aged and inflamed IL-10-\/- mice","volume":"77","author":"Saleh","year":"2022","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.molmed.2025.10.001_bb0525","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.2215\/CJN.07280622","article-title":"Calamari, hyperkalemia, and renin-angiotensin system blockade","volume":"17","author":"Janak","year":"2022","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0530","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00125-019-4888-z","article-title":"Novel therapeutic potential of angiotensin receptor 1 blockade in a rat model of diabetes-associated depression parallels altered BDNF signalling","volume":"62","author":"Lenart","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.molmed.2025.10.001_bb0535","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-79096-2","article-title":"Chronically infused angiotensin II induces depressive-like behavior via microglia activation","volume":"10","author":"Park","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2025.10.001_bb0540","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/s41380-019-0415-3","article-title":"The molecular and cellular mechanisms of depression: a focus on reward circuitry","volume":"24","author":"Fox","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.molmed.2025.10.001_bb0545","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bcp.2015.05.006","article-title":"Dopamine D2 and angiotensin II type 1 receptors form functional heteromers in rat striatum","volume":"96","author":"Martinez-Pinilla","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0550","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10571-015-0327-y","article-title":"Evidence to consider angiotensin II receptor blockers for the treatment of early Alzheimer\u2019s disease","volume":"36","author":"Saavedra","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0555","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1137197","article-title":"Neuroprotective effect of angiotensin II receptor blockers on the risk of incident Alzheimer's disease: a nationwide population-based cohort study","volume":"15","author":"Lee","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.molmed.2025.10.001_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103850","article-title":"Potential molecular pathways of angiotensin receptor blockers in the brain toward cognitive improvement in dementia","volume":"29","author":"Karmakar","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.molmed.2025.10.001_bb0565","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1176\/appi.ajp.2019.19050561","article-title":"Augmenting computerized cognitive training with vortioxetine for age-related cognitive decline: a randomized controlled trial","volume":"177","author":"Lenze","year":"2020","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.molmed.2025.10.001_bb0570","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jagp.2023.01.004","article-title":"Combined cognitive training and vortioxetine mitigates age-related declines in functional brain network integrity","volume":"31","author":"Waring","year":"2023","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.molmed.2025.10.001_bb0575","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13195-024-01505-9","article-title":"The cognitive effect of non-invasive brain stimulation combined with cognitive training in Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis","volume":"16","author":"Yang","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.molmed.2025.10.001_bb0580","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/gbb.12235","article-title":"Angiotensin type 1a receptors on corticotropin-releasing factor neurons contribute to the expression of conditioned fear1","volume":"14","author":"Hurt","year":"2015","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.molmed.2025.10.001_bb0585","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.mayocp.2022.06.036","article-title":"Effect of the renin-angiotensin system inhibitors on inflammatory markers: a systematic review and meta-analysis of randomized controlled trials","volume":"97","author":"Awad","year":"2022","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.molmed.2025.10.001_bb0590","first-page":"856","article-title":"Angiotensin II type 1 receptor blocker losartan attenuates locomotor, anxiety-like behavior, and passive avoidance learning deficits in a sub-chronic stress model","volume":"21","author":"Ranjbar","year":"2018","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.molmed.2025.10.001_bb0595","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.pnpbp.2018.10.010","article-title":"The hypothalamic-pituitary-adrenal axis in PTSD: Pathophysiology and treatment interventions","volume":"89","author":"Dunlop","year":"2019","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.molmed.2025.10.001_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108704","article-title":"Angiotensin II type 1 receptor blockade attenuates posttraumatic stress disorder-related chronic pain by inhibiting glial activation in the spinal cord","volume":"196","author":"Hong","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.molmed.2025.10.001_bb0605","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3981790","article-title":"Central infusion of angiotensin ii type 2 receptor agonist compound 21 attenuates DOCA\/Nacl-induced hypertension in female rats","volume":"2016","author":"Dai","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.molmed.2025.10.001_bb0610","doi-asserted-by":"crossref","first-page":"H191","DOI":"10.1152\/ajpheart.01012.2013","article-title":"Estrogen regulation of the brain renin-angiotensin system in protection against angiotensin II-induced sensitization of hypertension","volume":"307","author":"Xue","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2025.116573","article-title":"Renin-angiotensin-aldosterone system activity in a female trauma-exposed sample","volume":"351","author":"Sinnott","year":"2025","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.molmed.2025.10.001_bb0620","doi-asserted-by":"crossref","DOI":"10.1080\/20008198.2021.1883923","article-title":"Comorbidity rates of posttraumatic stress disorder in dementia: a systematic literature review","volume":"12","author":"Sobczak","year":"2021","journal-title":"Eur. J. Psychotraumatol."},{"key":"10.1016\/j.molmed.2025.10.001_bb0625","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/wps.21110","article-title":"Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management","volume":"22","author":"Berk","year":"2023","journal-title":"World Psychiatry"},{"key":"10.1016\/j.molmed.2025.10.001_bb0630","doi-asserted-by":"crossref","first-page":"581","DOI":"10.5498\/wjp.v11.i9.581","article-title":"The renin-angiotensin system, mood, and suicide: are there associations?","volume":"11","author":"Sanches","year":"2021","journal-title":"World J. Psychiatry"},{"key":"10.1016\/j.molmed.2025.10.001_bb0635","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jad.2020.07.106","article-title":"Association between angiotensin receptor blockers and suicide: nationwide population-based propensity score matching study","volume":"276","author":"Lin","year":"2020","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.molmed.2025.10.001_bb0640","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.13304","article-title":"Association between angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and suicide","volume":"2","author":"Mamdani","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.molmed.2025.10.001_bb0645","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10528-020-09986-7","article-title":"Association of ACE gene insertion\/deletion polymorphism with suicidal attempt in an Iranian population","volume":"59","author":"Ghorbani","year":"2021","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.molmed.2025.10.001_bb0650","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s40263-019-00632-4","article-title":"The possible role of the angiotensin system in the pathophysiology of schizophrenia: implications for pharmacotherapy","volume":"33","author":"Oh","year":"2019","journal-title":"CNS Drugs"}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491425002394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491425002394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T10:02:13Z","timestamp":1778925733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491425002394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":130,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1471491425002394"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2025.10.001","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renin\u2013angiotensin system: a novel target for brain health","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2025.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}